| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $3,127,305 ) |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21DA055558 | Zebrafish Screens to Identify Agents which Reverse the Effects of Synthetic Opioids | 000 | 2 | NIH | 3/14/2024 | $154,500 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 5 | NIH | 4/5/2024 | $23,240 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AI153496 | Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesis | 000 | 5 | NIH | 4/18/2024 | $386,250 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 001 | 6 | NIH | 4/15/2024 | $17,672 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 000 | 6 | NIH | 1/11/2024 | $318,077 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 00 | 23 | HRSA | 1/26/2024 | $129,249 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 5 | NIH | 4/5/2024 | $364,090 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK134053 | Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | 000 | 2 | NIH | 1/31/2024 | $387,115 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R03AG080418 | Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease | 000 | 2 | NIH | 1/23/2024 | $136,598 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | T32GM144873 | Training in Molecular and translational Cell Dynamics | 000 | 3 | NIH | 4/17/2024 | $653,082 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01HD104418 | Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | 000 | 3 | NIH | 1/18/2024 | $479,823 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R00HL153896 | YAP1, neointima formation, and blood pressure regulation | 000 | 4 | NIH | 12/4/2023 | $224,101 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS122534 | Pre and post-synaptic pathways underlying the stress response in the adrenal medulla | 000 | 9 | NIH | 2/19/2024 | $333,140 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AI165521 | Novel antiviral mechanisms of the interferon system | 000 | 2 | NIH | 3/13/2024 | -$450,507 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 01 | 13 | HRSA | 4/19/2024 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | CE152617 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 4/15/2024 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | CE152617 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | CE152617 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 1/5/2024 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | CE152617 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | F31CA260842 | Targeting Gut Microbiota Metabolites to Prevent Liver Cancer | 001 | 2 | NIH | 12/28/2023 | -$12,651 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AG057598 | Development of Attenuated Furoxans as Novel Therapies for Alzheimer's Disease | 000 | 5 | NIH | 4/23/2024 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | CE146595 | Community Project Funding/Congressionally Directed Spending - Construction | 05 | 1 | HRSA | 1/6/2024 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | CE146595 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | F31CA260842 | Targeting Gut Microbiota Metabolites to Prevent Liver Cancer | 000 | 1 | NIH | 12/28/2023 | -$15,307 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | F31HL160178 | Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic Inflammation | 000 | 2 | NIH | 2/26/2024 | -$1,167 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21AI164449 | A novel model to study COVID-19 and Hypertension | 000 | 2 | NIH | 3/20/2024 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AI155545 | Anti-inflammatory functions for non-transcriptional IRF3 | 000 | 2 | NIH | 2/8/2024 | $0 |
| | 2024 | 2021 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01HL143082 | Genetic, Epigenetic and Dietary Salt effects on Microbiota and Hypertension | 000 | 4 | NIH | 12/28/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01HL137004 | Counter regulatory mechanisms of cardiotonic steroids in cardio-renal syndrome | 000 | 5 | NIH | 12/19/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA219144 | Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma | 000 | 6 | NIH | 1/18/2024 | $0 |
| | 2024 | 2020 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01MH110483 | Study of early brain alterations that predict development of chronic PTSD | 000 | 5 | NIH | 3/26/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $15,769,553 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI153496 | Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesis | 000 | 4 | NIH | 4/25/2023 | $386,250 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | F30AG079633 | AMPK localization, expression, and activity in Alzheimer's Disease | 000 | 2 | NIH | 7/27/2023 | $41,511 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 000 | 5 | NIH | 12/23/2022 | $318,077 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 001 | 5 | NIH | 3/17/2023 | $28,273 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01GM127656 | Effective targeting survivin dimerization interface with small molecule inhibitors | 000 | 5 | NIH | 5/23/2023 | $345,230 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 00 | 18 | CDC | 6/1/2023 | $86,963 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R00HL153896 | YAP1, neointima formation, and blood pressure regulation | 001 | 3 | NIH | 7/25/2023 | $43,529 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R00HL153896 | YAP1, neointima formation, and blood pressure regulation | 000 | 3 | NIH | 11/23/2022 | $249,000 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01HL152162 | Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicine | 000 | 3 | NIH | 5/22/2023 | $451,268 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R03AG080418 | Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease | 000 | 1 | NIH | 1/31/2023 | $149,050 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01NS122534 | Pre and post-synaptic pathways underlying the stress response in the adrenal medulla | 000 | 8 | NIH | 2/16/2023 | $370,159 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI146172 | Dissecting catalytic and regulatory functions of nonsegmented negative strandRNA viral polymerases | 000 | 5 | NIH | 5/26/2023 | $347,625 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | CE152617 | Community Project Funding/Congressionally Directed Spending - Construction | 00 | 1 | HRSA | 9/21/2023 | $1,000,000 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA258682 | Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | 000 | 2 | NIH | 7/17/2023 | $400,551 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R35GM150588 | Control of Klebsiella capsule biosynthesis and attachment | 000 | 1 | NIH | 8/29/2023 | $386,250 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21CA277252 | Targeting FASN to eliminate metastatic breast cancer in the brain | 000 | 1 | NIH | 7/8/2023 | $180,572 |
| | 2023 | 2023 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 4 | NIH | 3/23/2023 | $376,898 |
|
